|
Laverne pregunto:
Just over two years http://www.salacela.net/coleccion/13/ fluticasone ointment GSK has recently seen some encouraging progress with itspipeline of new drugs - including approvals this year for newtreatments for lung disease, cancer and HIV - but austeritypressures in Europe remain a drag on sales and profits. |
|
|
|
